A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial

समान संसाधन

• A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.
  द्वारा: Pace, D, और अन्य
  प्रकाशित: (2008)
• Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
  द्वारा: Khatami, A, और अन्य
  प्रकाशित: (2012)
• Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.
  द्वारा: Khatami, A, और अन्य
  प्रकाशित: (2013)
• What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries?
  द्वारा: Scott, J, और अन्य
  प्रकाशित: (2008)
• Immunogenicity and safety of a low-dose diphtheria, tetanus and acelular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
  द्वारा: Collins, C, और अन्य
  प्रकाशित: (2004)